Thursday, December 15, 2016

Translational Software Selected By MedTek21

Bellevue-based Translational Software, a provider of software for managing genomic and molecular data for personalized medicine, said today that it has been selected by fellow software provider MedTek21. According to Translational Software, it has been selected by MedTek21 to provide pharmacogenomics (PGx)-based monitoring for MedTek21's population health and medication risk management platform. Financial details of the deal were not announced. Translational Software is led by CEO Don Rule.